Menin prevents liver steatosis through co-activation of peroxisome proliferator-activated receptor alpha
Related Experiment Video
Updated: May 28, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Peng Cheng1, Sheng Sheng Yang, Xian Gui Hu
1Department of General Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, People's Republic of China. dfbbcxjh@Gmail.com
Abstract:
Fatty liver is strongly associated with metabolic syndrome. Here, we show that the impaired hepatic expression of menin, the product of the MEN1 (multiple endocrine neoplasia type 1) tumor suppressor gene, represents a common feature of several fatty liver mouse models. The liver specific ablation of MEN1 gene expression in healthy mice induced hepatic steatosis under high-fat dietary conditions. Moreover, overexpression of menin in livers of steatotic db/db mice reduced liver triglyceride accumulation. At the molecular level, we found that menin acts synergistically with the nuclear receptor PPARα to control gene expression of fatty acid oxidation. Collectively, these data suggest a crucial role for menin as an integrator of the complex transcriptional network controlling hepatic steatosis.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression

